Ignite Creation Date:
2025-12-24 @ 7:14 PM
Ignite Modification Date:
2026-01-22 @ 6:55 AM
Study NCT ID:
NCT02556203
Status:
TERMINATED
Last Update Posted:
2020-01-13
First Post:
2015-09-05
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Global Study Comparing a rivAroxaban-based Antithrombotic Strategy to an antipLatelet-based Strategy After Transcatheter aortIc vaLve rEplacement to Optimize Clinical Outcomes
Sponsor:
Bayer
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2015-12-16
Start Date Type:
ACTUAL
Primary Completion Date:
2018-11-27
Primary Completion Date Type:
ACTUAL
Completion Date:
2018-11-27
Completion Date Type:
ACTUAL
First Submit Date:
2015-09-05
First Submit QC Date:
None
Study First Post Date:
2015-09-22
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2019-11-22
Results First Submit QC Date:
None
Results First Post Date:
2020-01-13
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2019-12-23
Last Update Post Date:
2020-01-13
Last Update Post Date Type:
ACTUAL